×
Brainsway EBIT Margin 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Brainsway ebit margin from 2018 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
View More
Brainsway EBIT Margin 2018-2025 | BWAY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Brainsway ebit margin from 2018 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$230.5B
Boston Scientific (BSX)
$157.1B
Stryker (SYK)
$149.8B
EssilorLuxottica (ESLOY)
$148.8B
Medtronic (MDT)
$119.5B
Lonza Group Ag (LZAGY)
$50.1B
Haleon (HLN)
$44.5B
ResMed (RMD)
$42.3B
Agilent Technologies (A)
$33.8B
GE HealthCare Technologies (GEHC)
$33.7B
Terumo (TRUMY)
$27.7B
Koninklijke Philips (PHG)
$26.7B
Insulet (PODD)
$23.4B
Zimmer Biomet Holdings (ZBH)
$20.9B
Smith & Nephew SNATS (SNN)
$16.4B
Baxter (BAX)
$12.5B
Sunny Optical Technology (SNPTF)
$10.8B
Demant (WILYY)
$8.1B
Bio-Rad Laboratories (BIO)
$7.8B
Lantheus Holdings (LNTH)
$3.8B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Envista Holdings (NVST)
$3.4B
Perrigo (PRGO)
$3.3B
Prestige Consumer Healthcare (PBH)
$3.2B
ICU Medical (ICUI)
$3B
Haemonetics (HAE)
$2.6B
LeMaitre Vascular (LMAT)
$2.2B
AtriCure (ATRC)
$1.8B
QuidelOrtho (QDEL)
$1.8B
Curaleaf Holdings (CURLF)
$1.7B